GLP1R and Alzheimer disease: These verdicts proposed that NEP inhibitors have a protective effect against AD development through increasing GLP‐1, NPY and substance P. However, NEP inhibitors may be implicated in the pathogenesis of AD through the increment of BK and NPs.